Literature DB >> 32273604

Lopinavir-ritonavir in severe COVID-19.

Hannah Stower1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32273604     DOI： 10.1038/s41591-020-0849-9

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  28 in total

1.  Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons.

Authors:  Julia Del Amo; Rosa Polo; Santiago Moreno; Asunción Díaz; Esteban Martínez; José Ramón Arribas; Inma Jarrín; Miguel A Hernán
Journal:  Epidemiology       Date:  2020-11       Impact factor: 4.822

2.  DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing.

Authors:  Mohamed Abdel-Basset; Hossam Hawash; Mohamed Elhoseny; Ripon K Chakrabortty; Michael Ryan
Journal:  IEEE Access       Date:  2020-09-15       Impact factor: 3.367

Review 3.  Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.

Authors:  Zhihong Zuo; Ting Wu; Liangyu Pan; Chenzhe Zuo; Yingchuo Hu; Xuan Luo; Liping Jiang; Zanxian Xia; Xiaojuan Xiao; Jing Liu; Mao Ye; Meichun Deng
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

4.  The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.

Authors:  Ensieh Vahedi; Mostafa Ghanei; Ali Ghazvini; Hossein Azadi; Morteza Izadi; Yunes Panahi; Saeid Fathi; Mahmood Salesi; Seyed Hassan Saadat; Amir Hossein Ghazale; Mohammad Rezapour; Abolfazl Mozafari; Nahid Zand; Mohammadreza Raesi Parsaei; Mohammad Hossein Ranjkesh; Ramezan Jafari; Fatemeh Movaseghi; Enayat Darabi
Journal:  Daru       Date:  2020-06-19       Impact factor: 3.117

5.  Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments.

Authors:  Nabab Khan; Xuesong Chen; Jonathan D Geiger
Journal:  Front Pharmacol       Date:  2020-10-29       Impact factor: 5.810

6.  COVID-19: general overview, pharmacological options and ventilatory support strategies.

Authors:  Francesco Menzella; Andrea Matucci; Alessandra Vultaggio; Chiara Barbieri; Mirella Biava; Chiara Scelfo; Matteo Fontana; Nicola Cosimo Facciolongo
Journal:  Multidiscip Respir Med       Date:  2020-11-09

7.  Real Clinical Practice and Therapeutic Management Following COVID-19 Crisis in two Hospitals in Iran: A Statistical and Conceptual View.

Authors:  Ali Najafi; Mostafa Ghanei; Ghasem Janbabaei; Ali Akbar Velayati; Seyed Hassan Saadat; Hamidreza Jamaati; Payam Tabarsi; Farzaneh Dastan; Malihe Ram; Enayat Darabi; Saeid Fathi; Mohammad Gholami Fesharaki; Amir Hosein Ghazale; Shahrzad Saloo
Journal:  Tanaffos       Date:  2020-11

8.  Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19.

Authors:  Kevin McCoy; Sateesh Gudapati; Lawrence He; Elaina Horlander; David Kartchner; Soham Kulkarni; Nidhi Mehra; Jayant Prakash; Helena Thenot; Sri Vivek Vanga; Abigail Wagner; Brandon White; Cassie S Mitchell
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.525

9.  Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report.

Authors:  Carlos Spuch; Marta López-García; Tania Rivera-Baltanás; Daniela Rodrígues-Amorím; José M Olivares
Journal:  Front Pharmacol       Date:  2020-08-27       Impact factor: 5.810

Review 10.  Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2.

Authors:  Faezeh Almasi; Fatemeh Mohammadipanah
Journal:  Transbound Emerg Dis       Date:  2020-08-03       Impact factor: 4.521
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.